Thomas Stangler Novartis

Thomas Stangler is a Regulatory CMC team lead for Biosimilars at Novartis. Thomas has > 10 years of experience in the development of Biosimilars for Novartis’ Sandoz division. He is a physicist by training and has professional experience in analytical characterization, process development & characterization, QbD implementation and the use of statistics in CMC development.